BIOLASE TECHNOLOGY INC
10-Q, EX-27, 2000-08-14
DENTAL EQUIPMENT & SUPPLIES
Previous: BIOLASE TECHNOLOGY INC, 10-Q, 2000-08-14
Next: NATIONAL BANK OF COMMERCE TRUST DIVISION /TN/, 13F-HR, 2000-08-14



<TABLE> <S> <C>

<PAGE>
<ARTICLE> 5
<LEGEND>
THIS SCHEDULE CONTAINS SUMMARY FINANCIAL INFORMATION EXTRACTED FROM THE
COMPANY'S CONSOLIDATED CONDENSED BALANCE SHEET AT JUNE 30, 2000 AND ITS
CONSOLIDATED CONDENSED STATEMENTS OF OPERATIONS FOR THE THREE AND SIX MONTH
PERIODS THEN ENDED.
</LEGEND>

<S>                                 <C>                     <C>
<PERIOD-TYPE>                       3-MOS                   6-MOS
<FISCAL-YEAR-END>                 DEC-31-2000             DEC-31-2000
<PERIOD-START>                    APR-01-2000             JAN-01-2000
<PERIOD-END>                      JUN-30-2000             JUN-30-2000
<CASH>                              3,422,430               3,422,430
<SECURITIES>                                0                       0
<RECEIVABLES>                       1,308,509               1,308,509
<ALLOWANCES>                        (117,745)               (117,745)
<INVENTORY>                           938,750                 938,750
<CURRENT-ASSETS>                    5,688,361               5,688,361
<PP&E>                              1,769,716               1,769,716
<DEPRECIATION>                    (1,346,315)             (1,346,315)
<TOTAL-ASSETS>                      6,277,576               6,277,576
<CURRENT-LIABILITIES>               3,588,030               3,588,030
<BONDS>                                     0                       0
                       0                       0
                                 0                       0
<COMMON>                               19,787                  19,787
<OTHER-SE>                          2,669,759               2,669,759
<TOTAL-LIABILITY-AND-EQUITY>        6,277,576               6,277,576
<SALES>                             2,258,806               3,785,832
<TOTAL-REVENUES>                    2,258,806               3,785,832
<CGS>                               1,219,753               2,210,517
<TOTAL-COSTS>                       1,219,753               2,210,517
<OTHER-EXPENSES>                      603,739               1,117,178
<LOSS-PROVISION>                            0                       0
<INTEREST-EXPENSE>                     34,119                  57,380
<INCOME-PRETAX>                     (887,776)             (1,919,872)
<INCOME-TAX>                                0                       0
<INCOME-CONTINUING>                 (887,776)             (1,919,872)
<DISCONTINUED>                              0                       0
<EXTRAORDINARY>                             0                       0
<CHANGES>                                   0                       0
<NET-INCOME>                        (887,776)             (1,919,872)
<EPS-BASIC>                             (.04)                   (.10)
<EPS-DILUTED>                           (.04)                   (.10)


</TABLE>


© 2022 IncJournal is not affiliated with or endorsed by the U.S. Securities and Exchange Commission